# Molecular control of blood vessel types at the regenerative interface for engineering of osteogenic and angiogenic periosteum mimetic

> **NIH NIH R01** · UNIVERSITY OF ROCHESTER · 2024 · $494,149

## Abstract

Abstract
 Autograft is considered the gold standard for large bone defect repair and reconstruction. The superior
healing potential of autografts is attributed to the robust osteogenic and angiogenic activities of periosteum– a
highly vascularized thin tissue membrane covering the outer surface of bone. To recapitulate the superior
healing potential of periosteum, a series of tissue engineering strategies have been developed, aiming to
construct a biomimetic tissue-engineered periosteum (TEP) for enhanced bone defect repair and
reconstruction. The success of these strategies hinges on a thorough understanding of the osteogenic and
angiogenic role of periosteum and a better insight into the intricate relationship between bone and vessel
forming cells at the regenerative interface of periosteum-mediated repair. Supported by NIH funding, we have
made a series of progresses in construction of a biomimetic functional periosteum and in understanding of the
functional vascular bed at the site of periosteal repair utilizing transgenic animals that label subtypes of
endothelial cells. Building on these progresses, the proposed work will focus on understanding the molecular
control of periosteum-mediated bone-specialized vessel formation, with further efforts devoted to building a
technological platform for controlled delivery of angiogenic and osteogenic factors for reconstruction of a pro-
angiogenic and pro-osteogenic periosteum mimetic for augmented bone allograft repair. The completion of the
proposed study will provide new insights into the molecular control of bone-specialized blood vessel formation
during periosteum-mediated repair, further offering engineering-based strategies targeting osteogenic and
angiogenic interface for augmented defect repair at a compromised periosteal site.

## Key facts

- **NIH application ID:** 10897874
- **Project number:** 5R01AR083224-02
- **Recipient organization:** UNIVERSITY OF ROCHESTER
- **Principal Investigator:** XINPING ZHANG
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $494,149
- **Award type:** 5
- **Project period:** 2023-08-02 → 2029-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10897874

## Citation

> US National Institutes of Health, RePORTER application 10897874, Molecular control of blood vessel types at the regenerative interface for engineering of osteogenic and angiogenic periosteum mimetic (5R01AR083224-02). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10897874. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*